iHuman Inc. Announces First Quarter 2024 Unaudited Financial Results
iHuman (NYSE: IH) reported its Q1 2024 unaudited financial results, showing an 11.4% revenue drop to RMB235 million (US$32.5 million) year-over-year. Gross profit also decreased to RMB168.1 million (US$23.3 million), with operating income falling to RMB17.5 million (US$2.4 million) from RMB56.7 million last year. Net income was RMB22.3 million (US$3.1 million), a significant decline from RMB53.6 million. Despite financial declines, average total MAUs reached a record 26.38 million, up 25.1%. The company launched new products and expanded internationally, with notable investments in AI and product development.
- Average total MAUs reached a record-high of 26.38 million, a 25.1% increase year-over-year.
- Gross margin improved to 71.5% from 70.0% last year.
- Continued profitability for the ninth consecutive quarter.
- Significant investments in AI research and product development aimed at long-term growth.
- Revenues decreased by 11.4% year-over-year to RMB235 million (US$32.5 million).
- Gross profit fell to RMB168.1 million (US$23.3 million) from RMB185.6 million last year.
- Operating income dropped to RMB17.5 million (US$2.4 million) compared to RMB56.7 million last year.
- Net income declined to RMB22.3 million (US$3.1 million) from RMB53.6 million last year.
- Total operating expenses increased by 16.9% to RMB150.6 million (US$20.9 million).
Insights
Revenues and Profitability: iHuman reported revenues of
The operating income shows a sharp decrease to
Operating Expenses: The total operating expenses rose by
For a retail investor, it's important to note the strategic investments that iHuman is making despite short-term profitability challenges. This indicates confidence in future growth, but it also carries risks if the investments don't yield the expected results.
Market Penetration and User Engagement: iHuman's strategy of leveraging advanced AI to enhance user engagement is notable. The record-high 26.38 million MAUs (monthly active users), a
International Expansion: Efforts to expand internationally with products like Aha Makeover and the bekids Library indicate iHuman's pursuit of a larger addressable market. This strategic diversification can help mitigate risks associated with the domestic market's saturation and regulatory environment. However, successful international expansion requires significant resources and understanding of local market dynamics.
Retail investors should consider the potential for growth in user base and market diversity, which can be substantial drivers for future revenue. However, they should also weigh the risks associated with increased operational expenses and the company's ability to scale effectively in new markets.
AI Integration and Product Innovation: iHuman's focus on enhancing their AI capabilities is central to their strategy. The introduction of AI-powered features such as the 'Challenge' feature in iHuman Magic Thinking and the real-time code debugging in iHuman Smart Coder indicates a robust commitment to creating personalized and adaptive learning experiences. These advancements can significantly boost user engagement and satisfaction by providing tailored educational content that adapts to the user's skill level.
Moreover, the integration of AR in products like Aha Makeover shows iHuman's drive to offer immersive and interactive experiences. These tech-driven enhancements can set iHuman apart from competitors by offering unique value propositions to users.
For investors, this technological edge means that iHuman is well-positioned to capitalize on emerging trends in educational technology. However, the long-term success of these innovations will depend on their adoption rates and the company's ability to continually improve and update their technologies to meet evolving user needs.
First Quarter 2024 Highlights
- Revenues were
RMB235.0 million (US ), compared with$32.5 million RMB265.2 million in the same period last year. - Gross profit was
RMB168.1 million (US ), compared with$23.3 million RMB185.6 million in the same period last year. - Operating income was
RMB17.5 million (US ), compared with$2.4 million RMB56.7 million in the same period last year. - Net income was
RMB22.3 million (US ), compared with$3.1 million RMB53.6 million in the same period last year. - Average total MAUs[1] reached a record-high of 26.38 million, a year-over-year increase of
25.1% .
[1] "Average total MAUs" refers to the monthly average of the sum of the MAUs of each of the Company's apps during a specific period, which is counted based on the number of unique mobile devices through which such app is accessed at least once in a given month, and duplicate access to different apps is not eliminated from the total MAUs calculation. |
Dr. Peng Dai, Director and Chief Executive Officer of iHuman, commented, "We started 2024 on a positive note, as our team precisely and efficiently executed our product roadmap to ensure our continued leadership in capturing user engagement. Central to our industry-leading product offerings are our high-quality content and advanced technological capabilities. In the first quarter, we continued to drive meaningful enhancements to our portfolio by leveraging these two strengths. Specifically, we intensified efforts to enhance our AI technologies and deepened their integration into our products to provide more dynamic and personalized experiences for our users. In June, we launched a brand-new product, iHuman Smart Coder, a full-year course developed and designed by iHuman's stellar team that was led by graduates from Tsinghua University. This course is designed to foster a scientific mindset and digital literacy for children by blending curated content with innovative, exploratory, interactive, and immersive activities. With a scientifically-structured curriculum benchmarked against accredited proficiency exams, the course aims to transform kids from coding novices to proficient problem solvers prepared for a digitalized future. It also offers kids comprehensive support through a three-tiered system: a chatbot for immediate queries, a real-time code debugging feature powered by our proprietary large language model, and personalized guidance from seasoned instructors. We are confident that this course will equip the young minds with the skills and confidence to navigate an ever-evolving futuristic world.
We have also enriched our existing products with more AI-enabled experiences. Within iHuman Magic Thinking, we introduced "Challenge", a new AI-powered feature that focuses on number literacy. Leveraging advanced AI algorithms, the new feature dynamically adapts the difficulty of questions to users' level, ensuring that young learners remain appropriately challenged. This facilitates effective practice while preventing kids from becoming excessively frustrated, thus maintaining their engagement and enthusiasm.
Beyond our domestic efforts, expanding our presence in international markets continues to be our strategic priority. Adhering to our product-driven strategy, we continued to drive market penetration by strengthening our product pipeline to meet the unique needs of international users. We recently expanded the Aha World brand with Aha Makeover, a customizable, DIY-fashion design app that offers young children a dynamic platform to unlock their creativity through personalized virtual styling experiences. Kids can choose from a diverse array of avatars, personalize their hairstyles, decorate their avatar with different accessories, and experiment with an extensive wardrobe for various occasions. Our cutting-edge AR technology then seamlessly integrates virtual and physical elements, offering kids an interactive experience where their creations come to life.
Furthermore, we are making more selected domestic products which we believe have cross-border appeal and audiences available beyond the Chinese mainland market. For example, we have recently rolled out bekids Library, the adapted version of iHuman Readers, a comprehensive leveled English reading app that we collaborate on with Oxford University Press. Now available in
Moving forward, our focus remains on enhancing our core competencies and creating high-quality and popular products to promote the holistic development of young children."
Ms. Vivien Weiwei Wang, Director and Chief Financial Officer of iHuman, added, "Throughout the first quarter, our steadfast commitment to product excellence continued to propel our business forward. Supported by high levels of user satisfaction and loyalty, our average total MAUs reached a record-high of 26.38 million, representing a year-over-year increase of
First Quarter 2024 Unaudited Financial Results
Revenues
Revenues were
Average total MAUs for the quarter reached a record-high of 26.38 million, an increase of
Cost of Revenues
Cost of revenues was
Gross Profit and Gross Margin
Gross profit was
Operating Expenses
Total operating expenses were
Research and development expenses were
Sales and marketing expenses were
General and administrative expenses were
Operating Income
Operating income was
Net Income
Net income was
Basic and diluted net income per ADS were
Deferred Revenue and Customer Advances
Deferred revenue and customer advances were
Cash, Cash Equivalents and Time Deposits
Cash, cash equivalents and time deposits were
Exchange Rate Information
The
Non-GAAP Financial Measures
iHuman considers and uses non-GAAP financial measures, such as adjusted operating income, adjusted net income and adjusted diluted net income per ADS, as supplemental metrics in reviewing and assessing its operating performance and formulating its business plan. The presentation of non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with accounting principles generally accepted in
Non-GAAP financial measures are not defined under
Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Statements that are not historical facts, including statements about iHuman's beliefs and expectations, are forward-looking statements. Among other things, the description of the management's quotations in this announcement contains forward-looking statements. iHuman may also make written or oral forward-looking statements in its periodic reports to the
About iHuman Inc.
iHuman Inc. is a leading provider of tech-powered, intellectual development products in
For more information about iHuman, please visit https://ir.ihuman.com/.
For investor and media enquiries, please contact:
iHuman Inc.
Mr. Justin Zhang
Investor Relations Director
Phone: +86 10 5780-6606
E-mail: ir@ihuman.com
Christensen
In
Ms. Alice Li
Phone: +86-10-5900-1548
E-mail: alice.li@christensencomms.com
In the US
Ms. Linda Bergkamp
Phone: +1-480-614-3004
E-mail: linda.bergkamp@christensencomms.com
iHuman Inc. | ||||||
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||
(Amounts in thousands of Renminbi ("RMB") and except for number of shares, ADSs, per share and per ADS data) | ||||||
December 31, | March 31, | March 31, | ||||
2023 | 2024 | 2024 | ||||
RMB | RMB | US$ | ||||
ASSETS | ||||||
Current assets | ||||||
Cash and cash equivalents | 1,213,767 | 890,805 | 123,375 | |||
Time deposits | - | 240,521 | 33,312 | |||
Accounts receivable, net | 60,832 | 68,068 | 9,427 | |||
Inventories, net | 16,518 | 17,247 | 2,389 | |||
Amounts due from related parties | 1,810 | 2,850 | 395 | |||
Prepayments and other current assets | 89,511 | 93,567 | 12,959 | |||
Total current assets | 1,382,438 | 1,313,058 | 181,857 | |||
Non-current assets | ||||||
Property and equipment, net | 6,169 | 5,504 | 762 | |||
Intangible assets, net | 23,245 | 22,080 | 3,058 | |||
Operating lease right-of-use assets | 3,648 | 3,235 | 448 | |||
Long-term investment | 26,333 | 26,333 | 3,647 | |||
Other non-current assets | 8,662 | 8,286 | 1,146 | |||
Total non-current assets | 68,057 | 65,438 | 9,061 | |||
Total assets | 1,450,495 | 1,378,496 | 190,918 | |||
LIABILITIES | ||||||
Current liabilities | ||||||
Accounts payable | 22,139 | 21,556 | 2,985 | |||
Deferred revenue and customer advances | 318,587 | 313,790 | 43,459 | |||
Amounts due to related parties | 4,428 | 22,710 | 3,145 | |||
Accrued expenses and other current liabilities | 143,677 | 94,054 | 13,026 | |||
Dividend payable | - | 37,525 | 5,197 | |||
Current operating lease liabilities | 1,927 | 1,823 | 252 | |||
Total current liabilities | 490,758 | 491,458 | 68,064 | |||
Non-current liabilities | ||||||
Non-current operating lease liabilities | 1,933 | 1,495 | 207 | |||
Total non-current liabilities | 1,933 | 1,495 | 207 | |||
Total liabilities | 492,691 | 492,953 | 68,271 | |||
SHAREHOLDERS' EQUITY | ||||||
Ordinary shares (par value of | 185 | 185 | 26 | |||
Additional paid-in capital | 1,088,628 | 994,532 | 137,741 | |||
Treasury stock | (16,665) | (17,922) | (2,482) | |||
Statutory reserves | 8,164 | 8,164 | 1,131 | |||
Accumulated other comprehensive income | 17,955 | 18,745 | 2,596 | |||
Accumulated deficit | (140,463) | (118,161) | (16,365) | |||
Total shareholders' equity | 957,804 | 885,543 | 122,647 | |||
Total liabilities and shareholders' equity | 1,450,495 | 1,378,496 | 190,918 |
iHuman Inc. | ||||||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||
(Amounts in thousands of Renminbi ("RMB") and | ||||||
For the three months ended | ||||||
March 31, | March 31, | March 31, | ||||
2023 | 2024 | 2024 | ||||
RMB | RMB | US$ | ||||
Revenues | 265,203 | 235,003 | 32,548 | |||
Cost of revenues | (79,636) | (66,892) | (9,264) | |||
Gross profit | 185,567 | 168,111 | 23,284 | |||
Operating expenses | ||||||
Research and development expenses | (61,673) | (67,923) | (9,407) | |||
Sales and marketing expenses | (40,435) | (54,995) | (7,617) | |||
General and administrative expenses | (26,735) | (27,724) | (3,840) | |||
Total operating expenses | (128,843) | (150,642) | (20,864) | |||
Operating income | 56,724 | 17,469 | 2,420 | |||
Other income, net | 6,082 | 9,010 | 1,248 | |||
Income before income taxes | 62,806 | 26,479 | 3,668 | |||
Income tax expenses | (9,160) | (4,177) | (579) | |||
Net income | 53,646 | 22,302 | 3,089 | |||
Net income per ADS: | ||||||
- Basic | 1.01 | 0.42 | 0.06 | |||
- Diluted | 0.98 | 0.41 | 0.06 | |||
Weighted average number of ADSs: | ||||||
- Basic | 52,953,297 | 52,729,148 | 52,729,148 | |||
- Diluted | 54,763,570 | 54,691,599 | 54,691,599 | |||
Total share-based compensation expenses included in: | ||||||
Cost of revenues | 98 | 40 | 6 | |||
Research and development expenses | 638 | 457 | 63 | |||
Sales and marketing expenses | 379 | 46 | 6 | |||
General and administrative expenses | 1,292 | 301 | 42 |
iHuman Inc. | ||||||
UNAUDITED RECONCILIATION OF GAAP AND NON-GAAP RESULTS | ||||||
(Amounts in thousands of Renminbi ("RMB") and | ||||||
For the three months ended | ||||||
March 31, | March 31, | March 31, | ||||
2023 | 2024 | 2024 | ||||
RMB | RMB | US$ | ||||
Operating income | 56,724 | 17,469 | 2,420 | |||
Share-based compensation expenses | 2,407 | 844 | 117 | |||
Adjusted operating income | 59,131 | 18,313 | 2,537 | |||
Net income | 53,646 | 22,302 | 3,089 | |||
Share-based compensation expenses | 2,407 | 844 | 117 | |||
Adjusted net income | 56,053 | 23,146 | 3,206 | |||
Diluted net income per ADS | 0.98 | 0.41 | 0.06 | |||
Impact of non-GAAP adjustments | 0.04 | 0.01 | 0.00 | |||
Adjusted diluted net income per ADS | 1.02 | 0.42 | 0.06 | |||
Weighted average number of ADSs – diluted | 54,763,570 | 54,691,599 | 54,691,599 | |||
Weighted average number of ADSs – adjusted | 54,763,570 | 54,691,599 | 54,691,599 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/ihuman-inc-announces-first-quarter-2024-unaudited-financial-results-302185388.html
SOURCE iHuman Inc.
FAQ
What were iHuman's Q1 2024 revenues?
How did iHuman's net income for Q1 2024 compare to the same period last year?
What was iHuman's average total MAUs in Q1 2024?
What were iHuman's gross profit and margin in Q1 2024?